Innovating Works

FUNDACIO HOSPITAL UNIVERSITARI VALL HEBRON - INSTITUT DE RECERCA

Activa
Mostrando 1 al 20 de 100 resultados
VIDA: VHIO International postDoctoral programme for translAtional research FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON tramitó un HORIZON EUROPE: The proposed VHIO International postDoctoral programme for translAtional research (VIDA) aims at enabling outstanding junior scientists of a...
2024-09-12 - 2029-12-31 | Financiado
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado
EXPAND-EV: EXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision heal... Extracellular vesicles (EVs) have been identified as important signaling mediators in a myriad of physiological and pathological processes....
2024-08-19 - 2028-12-31 | Financiado
SYNTHIA: Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applica... SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in he...
2024-08-09 - 2029-08-31 | Financiado
UMBRELLA: Unleashing a CoMprehensive Holistic and Patient Centric Stroke Management for a Better Rapid Adva... "UMBRELLA is a holistic approach to progress, reshape, and benchmark the overall stroke care pathway and set new and improved standards of c...
2024-07-31 - 2029-09-30 | Financiado
SWEET: Social aWareness for sErvicE roboTs To develop autonomous robots that are able to comply with social conventions and expectations, and avoid rejection from humans requires that...
2024-07-12 - 2029-01-31 | Financiado
SPM4.0: Autonomous Scanning Probe Microscopy for Life Sciences and Medicine powered by Artificial Intelligen... Artificial Intelligence is pushing forward the Industrial Revolution 4.0, which is transforming many areas of Society, including Science and...
2024-07-05 - 2028-10-31 | Financiado
POC4TRIAGE: Point of Care Devices for Urgent Care Triage Cardiorespiratory diseases and stroke are among the top four leading causes of death in the EU in prehospital settings. Urgent care services...
2024-06-28 - 2028-06-30 | Financiado
EATRIS-CONNECT: EATRIS CONNECT Since the establishment of EATRIS as an ERIC in 2014, the infrastructure has developed a growing portfolio of services and collaborative pro...
2024-06-20 - 2027-04-30 | Financiado
HemaFAIR: Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases KYPRIAKO IDRYMA EREVNON GIA TI MYIKI DISTROFIA tramitó un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 Research on rare diseases (RDs) is scarce and fragmented in the EU, leading to delayed diagnoses, limited availability of medicinal products...
2024-05-21 - 2027-06-30 | Financiado
HydroTheC: Biodegradable and Eco-friendly Smart Hydrogels for the Sustained Intraperitoneal Release of Chemothe... FUNDACIO HOSPITAL UNIVERSITARI VALL HEBRON - INSTITUT DE RECERCA tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Ovarian Cancer (OC) is usually diagnosed in advanced stages when metastasis into the intra-abdominal (i.a.) cavity already occurred. The OC...
2023-04-28 - 2026-12-31 | Financiado
iMM-CARE: iMM-CARE: BOOSTING CLINICAL RESEARCH FOR THE BENEFIT OF SOCIETY INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES tramitó un HORIZON EUROPE: HORIZON-WIDERA-2022-ACCESS-01-two-stage IMM-CARE will deliver a pioneering Centre of Excellence (CoE) in human-centred clinical and translational research in Portugal by teaming up...
2023-04-26 - 2029-04-30 | Financiado
FLUTE: Federate Learning and mUlti-party computation Techniques for prostatE cancer INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-IND-13 The FLUTE project will advance and scale up data-driven healthcare by developing novel methods for privacy-preserving cross-border utilizati...
2023-04-04 - 2026-04-30 | Financiado
SHARESPACE: Embodied Social Experiences in Hybrid Shared Spaces DEUTSCHES FORSCHUNGSZENTRUM FUR KUNSTLICHE INTELLIGENZ GMBH tramitó un HORIZON EUROPE: HORIZON-CL4-2022-HUMAN-01 SHARESHARESPACE will demonstrate a radically new technology for promoting ethical and social interaction in eXtended Reality (XR) Shared Hyb...
2022-11-14 - 2025-12-31 | Financiado
SYNTHEMA: Synthetic generation of hematological data over federated computing frameworks UNIVERSIDAD POLITÉCNICA DE MADRID tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-IND-13 Haematological diseases (HDs) are a large group of disorders resulting from quantitative or qualitative abnormalities of blood cells, lympho...
2022-11-10 - 2026-11-30 | Financiado
FLIGHT: Fostering research careers in LIGHT sciences FUNDACIO INSTITUT DE CIENCIES FOTONIQUES tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-COFUND-01 FLIGHT is a 60-month MCSA COFUND doctoral program that aims at recruiting outstanding early stage researchers (ESRs) to carry out ambitious...
2022-10-11 - 2028-10-31 | Financiado
DataTools4Heart: A European Health Data Toolbox for Enhancing Cardiology Data Interoperability Reusability and Priva... UNIVERSIDAD DE BARCELONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Cardiovascular disease (CVD) remains the main cause of mortality worldwide, accounting for about a third of annual deaths. Re-use of both st...
2022-06-03 - 2026-09-30 | Financiado
HORUS: Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation UNIVERSITE DE BORDEAUX tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "Solid organ transplantation (SOT) is the treatment of choice for end-stage organ failure but the immunosuppressive drugs used to prevent gr...
2022-05-30 - 2027-10-31 | Financiado
UNDINE: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infect... AARHUS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "The consequences of SARS-CoV-2 exposure range from a lack of infection to lethal COVID-19. This immense inter-individual clinical variabili...
2022-05-20 - 2026-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.